Upgrade to SI Premium - Free Trial

Sarepta Therapeutics (SRPT) PT Lowered to $20 at JPMorgan

July 21, 2025 5:43 AM
JPMorgan analyst Anupam Rama lowered the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $20.00 (from $28.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles